Acetazolamide
- Product NDC
- 50742-233
- 11-digit product format
- 507420233
- Labeler code
- 50742
- Product ID
- 50742-233_7b0e4b3b-5f80-43bb-8a22-686d8323d86e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA203434
- Marketing category
- ANDA
- Marketing start
- 2017-07-31
- Substance
- ACETAZOLAMIDE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetazolamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 562524 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50742-233-01 | Acetazolamide | 100 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 100 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-233 | ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [INGENUS PHARMACEUTICALS, LLC] | 4 | Current NDC, Legacy NDC, 1 package rows | 20221217_a1f6ed35-9188-4115-8a3c-1ac91c07bf7d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-233-01 | 50742023301 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50742-233-01) | 2017-07-31 | 0000-00-00 | No | No | Current |